{
    "id": 24536,
    "cites": 34,
    "cited_by": 3,
    "reference": [
        "Acemoglu, Daron and Joshua Linn (2004) Market size in innovation: theory and evidence from the pharmaceutical industry. Quarterly Journal of Economics 119 (3), 1049-1090, August.",
        "Bertram, Melanie Y, Jeremy A Lauer, Kees De Joncheere, Tessa Edejer, Raymond Hutubessy, Marie-Paule Kieny and Suzanne R Hill (2016) Cost-effectiveness thresholds: pros and cons. Bulletin of the World Health Organization 94(12), 925-930, Dec 1.",
        "Bils, Mark (2004) Measuring the Growth from Better and Better Goods. National Bureau of Economic Research working paper no. 10606, July.",
        "Brustugun, OT, B M\u00c3\u0083\u00c2\u00b8ller, and A Helland (2014) Years of life lost as a measure of cancer burden on a national level. British Journal of Cancer 111, 1014\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1020. 21 Burnet, NG, SJ Jefferies, RJ Benson, DP Hunt, and FP Treasure (2005) Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds. British Journal of Cancer 92 (2), 241\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c5, January.",
        "Centre National Hospitalier d\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2Information sur le M\u00c3\u0083\u00c2\u00a9dicament (2017) Th\u00c3\u0083\u00c2\u00a9riaque database. http://www.theriaque.org/apps/contenu/accueil.php Chien, YiLi (2015) What Drives Long-Run Economic Growth?. Federal Reserve Bank of St. Louis.",
        "Cutler, David, Angus Deaton, and Adriana Lleras-Muney (2006) The Determinants of Mortality. Journal of Economic Perspectives 20(3), 97-120, Summer.",
        "Danzon, Patricia M, Y Richard Wang, and Liang Wang (2005) The impact of price regulation on the launch delay of new drugs\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009devidence from twenty-five major markets in the 1990s. Health Economics 14(3), 269-92, March.",
        "Ferlay J, F Bray, P Pisani, and D M Parkin (2004) GLOBOCAN 2002 Cancer Incidence, Mortality and Prevalence Worldwide, IARC CancerBase No. 5, version 2.0, IARCPress, Lyon.",
        "Fuchs, Victor R (2010) New Priorities for Future Biomedical Innovations. New England Journal of Medicine 363,704-706, August 19, Grossman, Gene M., and Elhanan Helpman (1993) Innovation and Growth in the Global Economy (Cambridge: MIT Press).",
        "Hercowitz, Zvi (1998) The &apos;embodiment&apos; controversy: A review essay. Journal of Monetary Economics 41, 217-224.",
        "IMS Institute for Healthcare Informatics (2015) Medicines Use and Spending Shifts: A Review of the Use of Medicines in the U.S. in 2014, April.",
        "IMS Institute for Healthcare Informatics (2016) Global Oncology Trend Report: A Review of 2015 and Outlook to 2020, June.",
        "International Agency for Research on Cancer (2017a) WHO Cancer Mortality Database.",
        "International Agency for Research on Cancer (2017b) GLOBOCAN 2012: Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012. 22 International Federation of Pharmaceutical Manufacturers & Associations (2017) The Pharmaceutical Industry and Global Health: Facts and Figures 2017. February, https://www.ifpma.org/wp-content/uploads/2017/02/IFPMA-Facts-And-Figures-2017.pdf Jones, Charles I (1998) Introduction to Economic Growth. New York: W.W. Norton.",
        "Jones Charles I (2002) Sources of U.S. Economic Growth in a World of Ideas. American Economic Review 92 (1): 220-239, March.",
        "Jovanovic Boyan, and Yuri Yatsenko (2012) Investment in Vintage Capital. Journal of Economic Theory 147(2), 551\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c569.",
        "Kirch, Wilhelm, ed. (2008) Encyclopedia of Public Health, Springer-Verlag Berlin Heidelberg.",
        "Lichtenberg Frank R (2014) The impact of pharmaceutical innovation on disability days and the use of medical services in the United States, 1997-2010. Journal of Human Capital 8(4), 432480, Winter.",
        "Lichtenberg Frank R (2015) The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011. International Journal of Health Economics and Management 15(3), 339-359, June.",
        "Lichtenberg Frank R (2016a) The impact of pharmaceutical innovation on cancer mortality in Belgium, 2004-2012. Forum for Health Economics and Policy 20:1.",
        "Lichtenberg Frank R (2016b) The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995-2012. European Journal of Health Economics 17 (7), 833\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c854, September.",
        "Lichtenberg Frank R (2017) The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003-2013. Latin American Economic Review 26:8, December.",
        "Lichtenberg Frank R, Waldfogel Joel (2009) Does Misery Love Company? Evidence from Pharmaceutical Markets Before and After the Orphan Drug Act. Michigan Telecommunications & Technology Law Review 335.",
        "Murphy Kevin M, and Robert H Topel (2006) The Value of Health and Longevity. Journal of Political Economy 114 (5).",
        "National Cancer Institute (2017) Enhancing Drug Discovery and Development.",
        "National Science Foundation (2017) R&D Expenditures by Industry Category.",
        "Nordhaus, William D (2005) Irving Fisher and The Contribution of Improved Longevity to Living Standards. American Journal of Economics and Sociology 64(1): 367-392, January. 23 OECD (2017) OECD Health Statistics database.",
        "Patterson, Gregory S (2012) The Business of Ideas: The Highs and Lows of Inventing and Extracting Revenue from Intellectual Property, AuthorHouse, September 14.",
        "Romer, Paul M (1990) Endogenous Technological Change. Journal of Political Economy 98(5, Pt. 2), S71\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009cS102, October.",
        "Sampat, Bhaven, Frank R Lichtenberg (2011) What are the Respective Roles of the Public and Private Sectors in Pharmaceutical Innovation?. Health Affairs 30(2), 332-9, Feb.",
        "Solow, Robert (1960) Investment and Technological Progress. In Mathematical methods in the social sciences, 1959, edited by Kenneth Arrow, Samuel Karlin, and Patrick Suppes. Stanford, CA: Stanford University Press.",
        "Somaini, Paulo, and Frank A Wolak (2016) An Algorithm to Estimate the Two-Way Fixed Effects Model. Journal of Econometric Methods 5(1): 143-152, January.",
        "United Nations (2017) Human Development Index (HDI) | Human Development Reports.",
        "World Health Organization (2016a) Global Health Estimates 2015: Disease burden by Cause, Age, Sex, by Country and by Region, 2000-2015. Geneva, World Health Organization; 2016."
    ]
}